nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—CHRM3—nephrolithiasis	0.819	1	CbGaD
Disopyramide—CHRM3—ureter—nephrolithiasis	0.0139	0.331	CbGeAlD
Disopyramide—SLC22A2—nephron—nephrolithiasis	0.0096	0.229	CbGeAlD
Disopyramide—Bad taste—Hydrochlorothiazide—nephrolithiasis	0.00875	0.0959	CcSEcCtD
Disopyramide—Sensation of warmth—Hydrochlorothiazide—nephrolithiasis	0.0082	0.0899	CcSEcCtD
Disopyramide—Epigastric pain—Hydrochlorothiazide—nephrolithiasis	0.00457	0.0501	CcSEcCtD
Disopyramide—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00406	0.0975	CbGpPWpGaD
Disopyramide—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.004	0.0962	CbGpPWpGaD
Disopyramide—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.00365	0.0877	CbGpPWpGaD
Disopyramide—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0034	0.0818	CbGpPWpGaD
Disopyramide—Fesoterodine—CHRM3—nephrolithiasis	0.00297	0.491	CrCbGaD
Disopyramide—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00288	0.0316	CcSEcCtD
Disopyramide—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.00281	0.0309	CcSEcCtD
Disopyramide—Numbness—Hydrochlorothiazide—nephrolithiasis	0.00266	0.0292	CcSEcCtD
Disopyramide—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.00255	0.028	CcSEcCtD
Disopyramide—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00251	0.0276	CcSEcCtD
Disopyramide—KCND3—cortex of kidney—nephrolithiasis	0.0025	0.0594	CbGeAlD
Disopyramide—CYP3A4—urine—nephrolithiasis	0.00248	0.059	CbGeAlD
Disopyramide—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00234	0.0256	CcSEcCtD
Disopyramide—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00221	0.0242	CcSEcCtD
Disopyramide—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00209	0.0229	CcSEcCtD
Disopyramide—SLC22A2—nephron tubule—nephrolithiasis	0.00207	0.0494	CbGeAlD
Disopyramide—SLC22A2—renal system—nephrolithiasis	0.00188	0.0449	CbGeAlD
Disopyramide—SLC22A2—kidney—nephrolithiasis	0.00182	0.0434	CbGeAlD
Disopyramide—SLC22A2—cortex of kidney—nephrolithiasis	0.00177	0.0422	CbGeAlD
Disopyramide—Isopropamide—CHRM3—nephrolithiasis	0.00175	0.289	CrCbGaD
Disopyramide—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0015	0.0165	CcSEcCtD
Disopyramide—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00146	0.0161	CcSEcCtD
Disopyramide—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00146	0.016	CcSEcCtD
Disopyramide—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00141	0.0155	CcSEcCtD
Disopyramide—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0014	0.0153	CcSEcCtD
Disopyramide—SLC22A1—renal system—nephrolithiasis	0.00133	0.0317	CbGeAlD
Disopyramide—Tolterodine—CHRM3—nephrolithiasis	0.00133	0.219	CrCbGaD
Disopyramide—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0013	0.0142	CcSEcCtD
Disopyramide—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0013	0.0142	CcSEcCtD
Disopyramide—SLC22A1—kidney—nephrolithiasis	0.00129	0.0306	CbGeAlD
Disopyramide—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00128	0.014	CcSEcCtD
Disopyramide—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00128	0.014	CcSEcCtD
Disopyramide—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00126	0.0138	CcSEcCtD
Disopyramide—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00115	0.0126	CcSEcCtD
Disopyramide—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00113	0.0124	CcSEcCtD
Disopyramide—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00111	0.0122	CcSEcCtD
Disopyramide—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0011	0.0121	CcSEcCtD
Disopyramide—CHRM3—renal system—nephrolithiasis	0.0011	0.0263	CbGeAlD
Disopyramide—CHRM3—kidney—nephrolithiasis	0.00107	0.0254	CbGeAlD
Disopyramide—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000991	0.0109	CcSEcCtD
Disopyramide—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000952	0.0104	CcSEcCtD
Disopyramide—Tension—Hydrochlorothiazide—nephrolithiasis	0.000948	0.0104	CcSEcCtD
Disopyramide—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000946	0.0104	CcSEcCtD
Disopyramide—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.000938	0.0103	CcSEcCtD
Disopyramide—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00091	0.00998	CcSEcCtD
Disopyramide—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.000896	0.0215	CbGpPWpGaD
Disopyramide—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.000896	0.00982	CcSEcCtD
Disopyramide—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.000885	0.0213	CbGpPWpGaD
Disopyramide—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.000882	0.00967	CcSEcCtD
Disopyramide—Malaise—Hydrochlorothiazide—nephrolithiasis	0.000871	0.00955	CcSEcCtD
Disopyramide—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000868	0.00951	CcSEcCtD
Disopyramide—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000866	0.00949	CcSEcCtD
Disopyramide—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000849	0.00931	CcSEcCtD
Disopyramide—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000822	0.00901	CcSEcCtD
Disopyramide—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000812	0.00891	CcSEcCtD
Disopyramide—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000804	0.00882	CcSEcCtD
Disopyramide—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000795	0.00871	CcSEcCtD
Disopyramide—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000788	0.00864	CcSEcCtD
Disopyramide—Shock—Hydrochlorothiazide—nephrolithiasis	0.000775	0.0085	CcSEcCtD
Disopyramide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000772	0.00846	CcSEcCtD
Disopyramide—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000762	0.00835	CcSEcCtD
Disopyramide—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000753	0.0181	CbGpPWpGaD
Disopyramide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000751	0.00824	CcSEcCtD
Disopyramide—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000744	0.0179	CbGpPWpGaD
Disopyramide—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000736	0.00807	CcSEcCtD
Disopyramide—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.000731	0.0176	CbGpPWpGaD
Disopyramide—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000713	0.00782	CcSEcCtD
Disopyramide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000708	0.00776	CcSEcCtD
Disopyramide—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000703	0.0077	CcSEcCtD
Disopyramide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000701	0.00768	CcSEcCtD
Disopyramide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000694	0.00761	CcSEcCtD
Disopyramide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000685	0.00751	CcSEcCtD
Disopyramide—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.000681	0.0164	CbGpPWpGaD
Disopyramide—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00068	0.0163	CbGpPWpGaD
Disopyramide—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00068	0.00745	CcSEcCtD
Disopyramide—Pain—Hydrochlorothiazide—nephrolithiasis	0.000674	0.00739	CcSEcCtD
Disopyramide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000674	0.00739	CcSEcCtD
Disopyramide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000649	0.00712	CcSEcCtD
Disopyramide—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.000634	0.0152	CbGpPWpGaD
Disopyramide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000626	0.00686	CcSEcCtD
Disopyramide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000623	0.00683	CcSEcCtD
Disopyramide—CYP3A4—renal system—nephrolithiasis	0.000606	0.0144	CbGeAlD
Disopyramide—CYP3A4—kidney—nephrolithiasis	0.000586	0.014	CbGeAlD
Disopyramide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000565	0.0062	CcSEcCtD
Disopyramide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000558	0.00611	CcSEcCtD
Disopyramide—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000549	0.0132	CbGpPWpGaD
Disopyramide—CHRM3—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000548	0.0132	CbGpPWpGaD
Disopyramide—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000542	0.013	CbGpPWpGaD
Disopyramide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000539	0.00591	CcSEcCtD
Disopyramide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000521	0.00571	CcSEcCtD
Disopyramide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000501	0.00549	CcSEcCtD
Disopyramide—Rash—Hydrochlorothiazide—nephrolithiasis	0.000497	0.00545	CcSEcCtD
Disopyramide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000496	0.00544	CcSEcCtD
Disopyramide—Headache—Hydrochlorothiazide—nephrolithiasis	0.000494	0.00541	CcSEcCtD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000479	0.0115	CbGpPWpGaD
Disopyramide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000468	0.00513	CcSEcCtD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000447	0.0107	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000438	0.0105	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000438	0.0105	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000409	0.00982	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000409	0.00982	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.000393	0.00945	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000377	0.00906	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000332	0.00799	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000332	0.00799	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00031	0.00744	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00031	0.00744	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000309	0.00744	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000309	0.00742	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000309	0.00742	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000309	0.00742	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000288	0.00692	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000288	0.00692	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000277	0.00665	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000276	0.00663	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000275	0.00662	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000273	0.00657	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000273	0.00657	CbGpPWpGaD
Disopyramide—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000268	0.00645	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000268	0.00645	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000265	0.00637	CbGpPWpGaD
Disopyramide—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000265	0.00637	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000257	0.00617	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000255	0.00612	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000255	0.00612	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000244	0.00585	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000227	0.00546	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000224	0.00538	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000223	0.00535	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000223	0.00535	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000208	0.00499	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000208	0.00499	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.0002	0.00481	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000173	0.00416	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000171	0.0041	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000169	0.00406	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000169	0.00406	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000157	0.00378	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000157	0.00378	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000157	0.00377	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000157	0.00377	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000148	0.00356	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000146	0.00352	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000146	0.00352	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000146	0.00352	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000145	0.00348	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00014	0.00336	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00014	0.00336	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000131	0.00314	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00013	0.00313	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00013	0.00313	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.00013	0.00313	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000129	0.0031	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.000119	0.00285	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.000118	0.00284	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.000117	0.00281	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000113	0.00271	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000112	0.00269	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000111	0.00268	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000104	0.00251	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000103	0.00248	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	0.000103	0.00247	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000102	0.00245	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GRHPR—nephrolithiasis	9.7e-05	0.00233	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GRHPR—nephrolithiasis	9.04e-05	0.00217	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	8.82e-05	0.00212	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	8.79e-05	0.00211	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	8.71e-05	0.00209	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AGXT—nephrolithiasis	8.65e-05	0.00208	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GRHPR—nephrolithiasis	8.35e-05	0.00201	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	8.24e-05	0.00198	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	8.21e-05	0.00197	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	8.13e-05	0.00196	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AGXT—nephrolithiasis	8.06e-05	0.00194	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	8.01e-05	0.00193	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	7.98e-05	0.00192	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	7.91e-05	0.0019	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AGXT—nephrolithiasis	7.44e-05	0.00179	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SLC26A1—nephrolithiasis	7.35e-05	0.00177	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—APRT—nephrolithiasis	7.35e-05	0.00177	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	7.01e-05	0.00168	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	6.98e-05	0.00168	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	6.92e-05	0.00166	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—APRT—nephrolithiasis	6.85e-05	0.00165	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SLC26A1—nephrolithiasis	6.85e-05	0.00165	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	6.38e-05	0.00153	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SLC26A1—nephrolithiasis	6.33e-05	0.00152	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APRT—nephrolithiasis	6.33e-05	0.00152	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	6.3e-05	0.00151	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	5.83e-05	0.0014	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	5.81e-05	0.0014	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	5.79e-05	0.00139	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	5.76e-05	0.00138	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	5.72e-05	0.00137	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	5.3e-05	0.00127	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	5.28e-05	0.00127	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AQP1—nephrolithiasis	5.24e-05	0.00126	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	5.23e-05	0.00126	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AQP1—nephrolithiasis	4.88e-05	0.00117	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CHRM3—nephrolithiasis	4.74e-05	0.00114	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	4.73e-05	0.00114	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.73e-05	0.00114	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	4.72e-05	0.00113	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.72e-05	0.00113	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	4.67e-05	0.00112	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.67e-05	0.00112	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AQP1—nephrolithiasis	4.51e-05	0.00108	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CHRM3—nephrolithiasis	4.41e-05	0.00106	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	3.42e-05	0.000822	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	3.38e-05	0.000812	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GRHPR—nephrolithiasis	3.26e-05	0.000785	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTH—nephrolithiasis	3.13e-05	0.000752	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTH—nephrolithiasis	3.12e-05	0.00075	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTH—nephrolithiasis	3.09e-05	0.000742	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AGXT—nephrolithiasis	2.91e-05	0.000699	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	2.47e-05	0.000595	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APRT—nephrolithiasis	2.47e-05	0.000595	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AQP1—nephrolithiasis	1.76e-05	0.000424	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CHRM3—nephrolithiasis	1.59e-05	0.000383	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	1.57e-05	0.000378	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	1.57e-05	0.000376	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	1.55e-05	0.000373	CbGpPWpGaD
